Quetiapine in Huntington's disease: A first case report [3]

Journal of Neurology

Volumn 249, Issue 8, 2002, Pages 1114-1115

  Bonelli, Raphael M ^a   Niederwieser, Gerald ^a  

^a Hospital BHB Eggenberg   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 4 RECEPTOR; HALOPERIDOL; OLANZAPINE; QUETIAPINE; TETRABENAZINE;

ADULT; CASE REPORT; CHOREA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; HUNTINGTON CHOREA; LETTER; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; HUNTINGTON DISEASE; RECOVERY OF FUNCTION;

EID: 0036041559     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0741-1     Document Type: Letter

References (12)

1. Olanzapine and Huntington's disease
2. Effectiveness of risperidone in Huntington chorea patients
3. The use of olanzapine for movement disorder in Huntington's disease: A first case report
4. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report
5. Psychopharmacologic treatment of pathologic aggression
6. Improvement of Huntington's disease with olanzapine and valproate
7. Use of risperidone in psychosis associated with Huntington's disease
8. Risperidone in treatment of choreoathetosis of Huntington's disease
9. Neuroleptically induced dystonia in Huntington's disease: A case report
10. Short-term effects of olanzapine in Huntington disease
11. Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography (SPET) study
12. Clozapine versus placebo in Huntington's disease: A double blind randomised comparative study